Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07204977 Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Late… |
Acamprosate calcium | Sclérose latérale amyotrophique | Phase 1 | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2026-02-02 → 2028-09-30 | Ouvrir |
| NCT07583030 A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relaps… |
LVIVO-TaVec400 product | Myasthénie | Phase 1 | WITHDRAWN | En attente / non publié | Union Hospital, Tongji Medical Co… | China · Beijing Tiantan Hospital, Capital Medical Uni… | 2026-09-23 → 2026-09-23 | Ouvrir |
| NCT06744920 RELIEVE — A Study to Investigate the Efficacy, Safety and Tolerability … |
Remibrutinib (Blinded) | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Brazil, Canada, … | 2025-02-07 → 2033-02-26 | Ouvrir |
| NCT05027269 MARINA — Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Pat… |
AOC 1001 | Myopathies | Phase 1/2 | COMPLETED | En attente / non publié | Avidity Biosciences, Inc. | United States · Kansas University Medical Center, Kan… | 2021-10-28 → 2023-02-14 | Ouvrir |
| NCT07856329 A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile… |
GNT0004 (1x10e13 vg/kg) | Myopathies | Phase 2/3 | RECRUITING | En attente / non publié | Genethon | Belgium, France, Spain, United Kingdom · Brest Univer… | 2021-03-01 → 2028-10-01 | Ouvrir |
| NCT07855887 Calcium Gluconate Activated in Anterior Disc Displacement With Reductio… |
activated platelet-rich plasma | Myopathies | Non applicable | RECRUITING | En attente / non publié | Cairo University | Egypt · Cairo University, Cairo, Egypt | 2026-07-25 → 2026-11 | Ouvrir |
| NCT05926596 Leg Stretching Using an Exoskeleton on Demand for People With Spasticity |
Wearable Robotic Exoskeleton | Myopathies | Non applicable | RECRUITING | En attente / non publié | VA Office of Research and Develop… | United States · Syracuse VA Medical Center, Syracuse,… | 2026-02-09 → 2027-04-30 | Ouvrir |
| NCT07855341 Low-Volume PENG Block With Dexamethasone vs Standard-Volume PENG Block … |
Pericapsular nerve group (PENG) b… | Myopathies | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Ain Shams University | Egypt · Ain Shams University Hospitals (El Demerdash … | 2026-10-15 → 2027-09-14 | Ouvrir |
| NCT05989815 WBPME — Effect of Whole-body Photobiomodulation on Muscular Performance… |
Photobiomodulation therapy (PBMT) | Myopathies | Non applicable | COMPLETED | En attente / non publié | Universidade Federal de Sao Carlos | Brazil · Desportivo Brasil Football Club, Porto Feliz… | 2023-07-10 → 2023-12-20 | Ouvrir |
| NCT06689124 A Randomized Study Comparing of Three Doses Nebulized Fentanyl in Older… |
Nebulized fentanyl | Myopathies | Phase 3 | COMPLETED | En attente / non publié | Bangkok Metropolitan Administrati… | Thailand · Faculty of Medicine,Vajira Hospital, Bangk… | 2024-07-01 → 2025-12-01 | Ouvrir |
| NCT07691970 ROSY-S — Rollover Study for Participants Who Have Completed a Previous … |
Anifrolumab | Myopathies | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Australia, Austria, Belgium… | 2026-08-31 → 2032-12-30 | Ouvrir |
| NCT06782490 MSS — A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-… |
BMS-986368 | Myopathies | Phase 2 | RECRUITING | En attente / non publié | Celgene | United States, Australia, Canada, Czechia, Germany, P… | 2025-06-05 → 2027-06-09 | Ouvrir |
| NCT07798609 A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynam… |
SFL-0821 for injection | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Soufflé Therapeutics, Inc. | Australia, New Zealand · Concord Repatriation General… | 2026-09 → 2028-04 | Ouvrir |
| NCT07782450 A Study to Learn About a Medicine Called PF-08154225 in Participants Wi… |
PF-08154225 | Myopathies | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Pfizer | Non communiqué | 2026-11-19 → 2031-02-22 | Ouvrir |
| NCT07287189 BASECAMP — Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients |
SAT-3247 | Myopathies | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Satellos Bioscience, Inc. | United States, Australia, Belgium, Canada, Poland, Se… | 2025-12-08 → 2028-02-28 | Ouvrir |
| NCT07704099 Safety and Efficacy of KER-065 in Participants With Duchenne Muscular D… |
KER-065 | Myopathies | Phase 2 | RECRUITING | En attente / non publié | Keros Therapeutics, Inc. | New Zealand · NZCR-Christchurch, Christchurch, New Ze… | 2026-09-25 → 2028-09-23 | Ouvrir |
| NCT07587242 SAFARI44 — A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1… |
AOC 1044 | Myopathies | Phase 3 | RECRUITING | En attente / non publié | Avidity Biosciences, Inc. | Belgium, France, Germany, Italy, Netherlands, Spain, … | 2026-09-01 → 2030-07 | Ouvrir |
| NCT07844200 Bela-SLE — The Primary Objective of the Trial is to Evaluate the Effect… |
belantamab mafodotin to the exist… | Lupus | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Medical Association for the Study… | Non communiqué | 2027-02 → 2031-12 | Ouvrir |
| NCT07038447 A Study of KITE-363 in Participants With Refractory Autoimmune Diseases |
KITE-363 | Lupus | Phase 1 | ENROLLING_BY_INVITATION | En attente / non publié | Kite, A Gilead Company | United States, Australia, Canada, South Korea · ASAN … | 2025-07-02 → 2030-09 | Ouvrir |
| NCT05411016 A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupu… |
KK4277 | Lupus | Phase 1 | COMPLETED | En attente / non publié | Kyowa Kirin Co., Ltd. | Japan, South Korea · Ajou University Hospital, Suwon,… | 2022-08-03 → 2025-10-27 | Ouvrir |
| NCT04643067 Lupus — Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in… |
KPG-818 low dose in phase 1b | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Kangpu Biopharmaceuticals, Ltd. | United States · Accurate Clinical Management, Houston… | 2021-06-03 → 2023-06-29 | Ouvrir |
| NCT07299422 A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus |
SHR-2173 injection | Lupus | Phase 2 | RECRUITING | En attente / non publié | Guangdong Hengrui Pharmaceutical … | China · Chinese Academy of Medical Sciences, Peking U… | 2026-04-03 → 2028-11 | Ouvrir |
| NCT07083349 NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus |
NK510 : allogeneic genetic modifi… | Lupus | Phase 1 | TERMINATED | En attente / non publié | Base Therapeutics (Shanghai) Co.,… | China · The First Affiliated Hospital of Anhui Medica… | 2025-12-01 → 2026-04-01 | Ouvrir |
| NCT07799116 CART-NEL — Study to Evaluate the Safety and Preliminary Efficacy of CD1… |
TranspoCART19 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Instituto de Investigación Sanita… | Spain · Clinica Universidad de Navarra, Pamplona, Spa… | 2026-09-23 → 2030-09 | Ouvrir |
| NCT07855302 CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythe… |
SNUH-CD19-CAR-T Cells | Lupus | Phase 1 | RECRUITING | En attente / non publié | Seoul National University Hospital | South Korea · Seoul National University Hospital, Seo… | 2026-09-14 → 2028-12 | Ouvrir |